Back to Search
Start Over
Chugai Pharma seeks Japanese approval for humanized anti-CD20 monoclonal antibody, Gazyva to treat CLL
- Source :
- PharmaBiz. March 8, 2022
- Publication Year :
- 2022
-
Abstract
- Chugai Pharmaceutical Co., Ltd. and Nippon Shinyaku Co., Ltd. announced that Chugai filed a regulatory application with the Ministry of Health, Labour and Welfare (MHLW), for approval of an anti-cancer [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.696053428